Frontiers | A Reciprocal Link Between Gut Microbiota, Inflammation and Depression: A Place for Probiotics?
Closed-loop neuromodulation in an individual with treatment-resistant depression | Nature Medicine
Video Capsule Endoscopy and Ingestible Electronics: Emerging Trends in Sensors, Circuits, Materials, Telemetry, Optics, and Rapid Reading Software | Advanced Devices & Instrumentation
The role of adenosine receptors in mood and anxiety disorders - Calker - 2019 - Journal of Neurochemistry - Wiley Online Library
Cybin Announces Unprecedented Positive Phase 2 Interim Data for CYB003 in Major Depressive Disorder Meeting Primary Efficacy Endpoint with Rapid and Significant Improvements in Depression Symptoms After Single Dose | Business &
IJMS | Free Full-Text | The Entorhinal Cortex and Adult Neurogenesis in Major Depression
White Matter Tract Integrity of Anterior Limb of Internal Capsule in Major Depression and Type 2 Diabetes | Neuropsychopharmacology
IJMS | Free Full-Text | Depression and Its Phytopharmacotherapy—A Narrative Review
Deep brain stimulation for treatment of refractory depression - The Lancet
Amazon.com: Microbiome Plus Gastrointestinal Probiotics L Reuteri NCIMB 30242 GI Digestive Supplements Capsule, Allergy Safe & Gluten Free for Men and Women (1 Month Supply) : Health & Household
PharmaWell - NeuroHS • CHD-FA™ Fulvic Acid
Focused Ultrasound and Psychiatric Disorders - Focused Ultrasound Foundation
IJMS | Free Full-Text | Neural Circuitry–Neurogenesis Coupling Model of Depression
Gut microbiota and its metabolites in depression: from pathogenesis to treatment - eBioMedicine
Startup Cerebral Soared on Easy Adderall Prescriptions. That Was Its Undoing. - WSJ
Gut microbiota and its metabolites in depression: from pathogenesis to treatment - eBioMedicine
Frontiers | The ventral capsule and ventral striatum—Stereotactic targets for the management of treatment-resistant depression. A systematic literature review
Cybin Announces Unprecedented Positive Phase 2 Interim Data for CYB003 in Major Depressive Disorder Meeting Primary Efficacy Endpoint with Rapid and Significant Improvements in Depression Symptoms After Single Dose | Business &
Frontiers | Neuroendocrine pathogenesis of perimenopausal depression
Functional connectomics in depression: insights into therapies: Trends in Cognitive Sciences
Merck asks EU regulator to authorize its COVID-19 pill | KARK